BACKGROUND AND PURPOSE: Various CTP parameters have been used to identify ischemic penumbra. The purpose of this study was to determine the optimal CTP parameter and threshold to distinguish true "at-risk" penumbra from benign oligemia in acute stroke patients without reperfusion. MATERIALS AND METHODS: Consecutive stroke patients were screened and 23 met the following criteria: 1) admission scanning within 9 hours of onset, 2) CTA confirmation of large vessel occlusion, 3) no late clinical or radiographic evidence of reperfusion, 4) no thrombolytic therapy, 5) DWI imaging within 3 hours of CTP, and 6) either CT or MR follow-up imaging. CTP was postprocessed with commercial software packages, using standard and delay-corrected deconvolution algorithms. Relative cerebral blood flow, volume, and mean transit time (rCBF, rCBV and rMTT) values were obtained by normalization to the uninvolved hemisphere. The admission DWI and final infarct were transposed onto the CTP maps and receiver operating characteristic curve analysis was performed to determine optimal thresholds for each perfusion parameter in defining penumbra destined to infarct. RESULTS: Relative and absolute MTT identified penumbra destined to infarct more accurately than CBF or CBV*CBF (P < .01). Absolute and relative MTT thresholds for defining penumbra were 12s and 249% for the standard and 13.5s and 150% for the delay-corrected algorithms, respectively. CONCLUSIONS: Appropriately thresholded absolute and relative MTT-CTP maps optimally distinguish "at-risk" penumbra from benign oligemia in acute stroke patients with large-vessel occlusion and no reperfusion. The precise threshold values may vary, however, depending on the postprocessing technique used for CTP map construction.
BACKGROUND AND PURPOSE: Various CTP parameters have been used to identify ischemic penumbra. The purpose of this study was to determine the optimal CTP parameter and threshold to distinguish true "at-risk" penumbra from benign oligemia in acute strokepatients without reperfusion. MATERIALS AND METHODS: Consecutive strokepatients were screened and 23 met the following criteria: 1) admission scanning within 9 hours of onset, 2) CTA confirmation of large vessel occlusion, 3) no late clinical or radiographic evidence of reperfusion, 4) no thrombolytic therapy, 5) DWI imaging within 3 hours of CTP, and 6) either CT or MR follow-up imaging. CTP was postprocessed with commercial software packages, using standard and delay-corrected deconvolution algorithms. Relative cerebral blood flow, volume, and mean transit time (rCBF, rCBV and rMTT) values were obtained by normalization to the uninvolved hemisphere. The admission DWI and final infarct were transposed onto the CTP maps and receiver operating characteristic curve analysis was performed to determine optimal thresholds for each perfusion parameter in defining penumbra destined to infarct. RESULTS: Relative and absolute MTT identified penumbra destined to infarct more accurately than CBF or CBV*CBF (P < .01). Absolute and relative MTT thresholds for defining penumbra were 12s and 249% for the standard and 13.5s and 150% for the delay-corrected algorithms, respectively. CONCLUSIONS: Appropriately thresholded absolute and relative MTT-CTP maps optimally distinguish "at-risk" penumbra from benign oligemia in acute strokepatients with large-vessel occlusion and no reperfusion. The precise threshold values may vary, however, depending on the postprocessing technique used for CTP map construction.
Authors: Ona Wu; Leif Østergaard; Robert M Weisskoff; Thomas Benner; Bruce R Rosen; A Gregory Sorensen Journal: Magn Reson Med Date: 2003-07 Impact factor: 4.668
Authors: Shahmir Kamalian; Shervin Kamalian; Matthew B Maas; Greg V Goldmacher; Seyedmehdi Payabvash; Adnan Akbar; Pamela W Schaefer; Karen L Furie; R Gilberto Gonzalez; Michael H Lev Journal: Stroke Date: 2011-05-05 Impact factor: 7.914
Authors: G Rordorf; W J Koroshetz; W A Copen; S C Cramer; P W Schaefer; R F Budzik; L H Schwamm; F Buonanno; A G Sorensen; G Gonzalez Journal: Stroke Date: 1998-05 Impact factor: 7.914
Authors: B D Murphy; A J Fox; D H Lee; D J Sahlas; S E Black; M J Hogan; S B Coutts; A M Demchuk; M Goyal; R I Aviv; S Symons; I B Gulka; V Beletsky; D Pelz; V Hachinski; R Chan; T-Y Lee Journal: Stroke Date: 2006-06-08 Impact factor: 7.914
Authors: Max Wintermark; Marc Reichhart; Jean-Philippe Thiran; Philippe Maeder; Marc Chalaron; Pierre Schnyder; Julien Bogousslavsky; Reto Meuli Journal: Ann Neurol Date: 2002-04 Impact factor: 10.422
Authors: Max Wintermark; Adam E Flanders; Birgitta Velthuis; Reto Meuli; Maarten van Leeuwen; Dorit Goldsher; Carissa Pineda; Joaquin Serena; Irene van der Schaaf; Annet Waaijer; James Anderson; Gary Nesbit; Igal Gabriely; Victoria Medina; Ana Quiles; Scott Pohlman; Marcel Quist; Pierre Schnyder; Julien Bogousslavsky; William P Dillon; Salvador Pedraza Journal: Stroke Date: 2006-03-02 Impact factor: 7.914
Authors: N Sillanpää; J T Saarinen; H Rusanen; I Elovaara; P Dastidar; S Soimakallio Journal: AJNR Am J Neuroradiol Date: 2012-06-21 Impact factor: 3.825
Authors: K Barlinn; J Seibt; K Engellandt; J Gerber; V Puetz; J Kepplinger; O Wunderlich; L-P Pallesen; U Bodechtel; R Koch; R von Kummer; I Dzialowski Journal: Clin Neuroradiol Date: 2014-08-23 Impact factor: 3.649
Authors: A J Riordan; E Bennink; M A Viergever; B K Velthuis; J W Dankbaar; H W A M de Jong Journal: AJNR Am J Neuroradiol Date: 2013-01-31 Impact factor: 3.825
Authors: Branko N Huisa; William P Neil; Ronald Schrader; Marcel Maya; Benedict Pereira; Nhu T Bruce; Patrick D Lyden Journal: J Stroke Cerebrovasc Dis Date: 2012-12-14 Impact factor: 2.136
Authors: Olvert A Berkhemer; Shervin Kamalian; R Gilberto González; Charles B L M Majoie; Albert J Yoo Journal: Cardiovasc Eng Technol Date: 2013-12-01 Impact factor: 2.495